[Dinitrosorbilong--a new Soviet anti-angina preparation. Its comparative pharmacodynamic, pharmacokinetic and clinical study].
The efficacy of dinitrosorbilong (DNL)--a new long-acting isosorbid dinitrate (IDN) preparation applied to the gum--was evaluated in 72 coronary patients with stable angina of effort. Repeated treadmill tests revealed antianginal effect of DNL exceeding 8 hours. The degree and duration of DNL action significantly surpassed those of conventional oral IDN tablets and of some other long-acting IDN preparations. The results of pharmacokinetic studies show that DNL bioavailability is 491 +/- 240% as compared to conventional oral IDN tablets. Regular 7-day DNL administration resulted in a significant decrease in the frequency of anginal attacks and in the daily consumption of nitroglycerin tablets as compared not only to the control period but also to the period of conventional IDN tablet therapy.
D000787:Angina Pectoris / Q000188:drug therapy* / Q000378:metabolism; D003327:Coronary Disease / Q000188:drug therapy / Q000378:metabolism; D003692:Delayed-Action Preparations; D004341:Drug Evaluation; D005080:Exercise Test; D006801:Humans; D007548:Isosorbide Dinitrate / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use; D007700:Kinetics; D005996:Nitroglycerin / Q000627:therapeutic use; D005082:Physical Exertion; D013607:Tablets
D003692:Delayed-Action Preparations; D013607:Tablets; D005996:Nitroglycerin; D007548:Isosorbide Dinitrate
Dinitrosorbilong--novyĭ otechestvennyĭ antianginal'nyĭ preparat. Sravnitel'noe farmakodinamicheskoe, farmakokineticheskoe i klinicheskoe izuchenie.